What is Gardasil 9?
Gardasil 9 is the latest breakthrough in cancer prevention that has the potential to save countless lives., offering protection against many cancers caused by nine different types of human papillomavirus (HPV). HPV is a virus spread through sexual contact and can cause many types of cancer. Gardasil 9 was approved by the U.S. Food and Drug Administration (FDA) in 2014. This revolutionary vaccine has been proven to reduce the risk of cervical, vulvar, vaginal, and anal cancers and genital warts. Gardasil 9 is the most advanced vaccine available today and is recommended for males and females between the ages of 9 and 45. This blog post will provide an overview of Gardasil 9’s benefits in preventing cancer, its potential risks, how it works, and why it is important for everyone, regardless of age or gender, to get vaccinated.
Gardasil 9; The Newest Breakthrough
Gardasil 9 is a recombinant vaccine, meaning that it is made from pieces of the virus’s genetic material. The vaccine works by triggering the body’s immune system to create antibodies against the nine types of HPV. These types are the same ones that cause most cases of cervical cancer and other types of cancer, such as anal, vulvar, and vaginal cancers. It’s worth mentioning that the number 9 in “Gardasil 9” represents its protection against nine types of human papillomavirus (the HPV virus). Gardasil 9 was approved by the U.S. Food and Drug Administration (FDA) in December 2014. The active ingredients in GARDASIL 9 are inactivated and recombinant proteins of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58, Aluminum (as aluminum hydroxide adjuvant), Sodium chloride, L-histidine, Polysorbate 80, Sodium borate, and Yeast protein.
Providing Protection
Gardasil 9 only offers protection against vulvar, vaginal, anal, oropharyngeal, and other head and neck cancers brought on by HPV Types 16, 18, 31, 33, 45, 52, and 58. Not all of these cancers are caused by HPV. External genital lesions, head and neck malignancies, cervical intraepithelial neoplasia (CIN), vulvar intraepithelial neoplasia (VIN), vaginal intraepithelial neoplasia (VaIN), and anal intraepithelial neoplasia are not treatable with GARDASIL 9. All in all, not everyone who receives the GARDASIL 9 vaccine will be protected from all types of HPV.
The Therapeutic Approach
HPV is not treated with GARDASIL 9. Even if you have already contracted one kind of HPV, it may still be possible for you to take steps to guard against cancers brought on by other strains of the virus that you haven’t yet been exposed to and that GARDASIL 9 helps prevent. You should be aware that it won’t cure your current HPV infection. Additionally, because the vaccine covers not all HPV varieties, frequent Pap exams are still necessary even if you receive the vaccine.
Dosage and Administration
Intramuscular injection of GARDASIL 9 is recommended in the deltoid or anterolateral region of the thigh. GARDASIL 9 can be administered on a 2-dose or 3-dose schedule to patients aged 9 to 14. When using a two-dosage schedule, the second dose should be given 6–12 months following the first. A third dose should be administered at least four months after the second dose if the second dose is given fewer than five months after the first dose. GARDASIL 9 should be given at 0, 2, and 6 months for the 3-dose plan. Gardasil 9 is delivered using a 3-dose plan at 0, 2 months, and six months to those aged 15 to 45. All three doses must be administered within a year for the vaccine to be effective.
Gardasil vs. Gardasil 9
Gardasil and Gardasil 9 are vaccines against certain types of human papillomavirus (HPV). Gardasil is a quadrivalent vaccine, meaning it protects against four types of HPV, while Gardasil 9 is a nonavalent vaccine, meaning it protects against nine types of HPV. Gardasil is a vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18. Gardasil 9 is an updated version of the Gardasil vaccine. It protects against the same four HPV types as Gardasil and five additional HPV types (31, 33, 45, 52, and 58). In terms of effectiveness, both vaccines are highly effective in protecting against HPV. A study conducted in 2018 found that Gardasil was 100% effective in preventing the four types of HPV it targets, while Gardasil 9 was 97% effective in preventing the nine types of HPV it targets. Gardasil and Gardasil 9 are highly effective in protecting against HPV, but Gardasil 9 is slightly more effective regarding the number of HPV types it targets.
Safety and Side Effects
The vaccine should not be administered to anyone extremely sensitive to yeast or components of GARDASIL 9 or GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]. The side effects of Gardasil 9 include headache, fever, nausea, and dizziness, in addition to pain, swelling, redness, itching, bruising, bleeding, and a lump where your child had a shot. After using GARDASIL 9, fainting may occur. People who faint occasionally collapse and harm themselves. Because of this, your doctor could advise your child to sit or lie down for 15 minutes after receiving Gardasil 9. Some persons who experience fainting may shiver or stiffen.
Conclusion
Gardasil 9 is a revolutionary vaccine designed to protect against nine types of HPV, including seven that can cause cancer. This groundbreaking breakthrough in cancer prevention has the potential to save thousands of lives each year. It is recommended for young people aged 9-45 and is given in two or three doses, depending on age. While some side effects are associated with the vaccine, most are mild and only last a short time. All in all, Gardasil 9 is an incredibly important tool in the fight against cancer and a great way to help protect yourself from the disease. By vaccinating, you can potentially reduce your risk of developing certain cancers caused by HPV and other serious health complications. Although it may not prevent all cervical cancer cases, it offers significant protection and should be taken seriously by individuals who fall into its target demographic.
